RT Journal Article
SR Electronic
T1 COVID-19 Scenarios: an interactive tool to explore the spread and associated morbidity and mortality of SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.05.20091363
DO 10.1101/2020.05.05.20091363
A1 Nicholas B Noll
A1 Ivan Aksamentov
A1 Valentin Druelle
A1 Abrie Badenhorst
A1 Bruno Ronzani
A1 Gavin Jefferies
A1 Jan Albert
A1 Richard A Neher
YR 2020
UL http://medrxiv.org/content/early/2020/05/12/2020.05.05.20091363.abstract
AB The ongoing SARS-CoV-2 pandemic has caused large outbreaks around the world and every heavily affected community has experienced a substantial strain on the health care system and a high death toll. Communities therefore have to monitor the incidence of COVID-19 carefully and attempt to project the demand for health care. To enable such projections, we have developed an interactive web application that simulates an age-structured SEIR model with separate compartments for severely and critically ill patients. The tool allows the users to modify most parameters of the model, including age specific assumptions on severity. Infection control and mitigation measures that reduce transmission can be specified, as well as age-group specific isolation.The simulation of the model runs entirely on the client side in the browser; all parameter settings and results of the simulation can be exported for further downstream analysis. The tool is available at covid19-scenarios.org and the source code at github.com/neherlab/covid19_scenarios.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by institutional core funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll source code and data are available on github.com/neherlab/covid19-scenarios https://github.com/neherlab/covid19-scenarios